Show MeThe answer to “Can nicotine be detected in a blood test?” is yes: a blood test can measure nicotine itself or its longer-lived metabolite cotinine in serum or plasma. Nicotine has a plasma half-life of about 2 hours, so direct levels fall quickly. Cotinine has a half-life of roughly 16 to 19 hours, so it remains measurable for about 1 to 3 days after use. Most clinical and research assays report nanograms per milliliter, and interpretation depends on the cutoff, timing, and whether exposure is active, passive, or from nicotine replacement therapy.
Can Nicotine Be Detected in a Blood Test? What the Assay Measures
Blood tests do not look for smoke; they look for molecules. Nicotine enters blood through the lungs, oral mucosa, or skin and reaches plasma within seconds to minutes. In serum or plasma, laboratories can measure nicotine and cotinine. Some panels add trans-3’-hydroxycotinine. Others add the minor tobacco alkaloids anabasine and anatabine. The parent drug is the least stable marker because it clears fast. Cotinine is the workhorse analyte because it is abundant and longer-lived. In plain terms: a good blood test usually hunts the metabolite, not the parent drug.
Half-life numbers explain the detection window. Nicotine’s plasma half-life is about 2 hours, with a range of roughly 1 to 4 hours. Cotinine’s half-life is about 16 to 19 hours, per a landmark 2009 review by Benowitz and colleagues. Trans-3’-hydroxycotinine clears faster than cotinine, around 5 to 6 hours. A single cigarette can produce a venous nicotine peak of roughly 5 to 30 ng/mL. The cotinine rise then continues for hours.
Method matters. Immunoassays are fast and cheap, with detection limits often around 1 to 10 ng/mL. LC-MS/MS is slower and costlier, but it can quantify cotinine near 0.015 ng/mL in the CDC’s NHANES laboratory methods. That difference changes what a positive result means. A test with a 10 ng/mL cutoff can miss low passive exposure that a 0.015 ng/mL assay would see.
Quantified comparison: a 10 ng/mL cutoff after a 200 ng/mL cotinine peak falls below threshold after roughly 4.3 half-lives, or about 69 to 82 hours. A 1 ng/mL cutoff takes about 7.6 half-lives, or 122 to 144 hours. The same sample can therefore be positive at one laboratory and negative at another. That is not a contradiction; it is a difference in assay sensitivity and the question being asked.
Detection Timeline in Blood
Detection is a race between clearance and assay cutoff. The timeline below assumes a single nicotine exposure and a typical serum cotinine half-life near 17 hours. Chronic heavy use shifts every row upward because cotinine accumulates. In plain terms: a blood test is a clock, not a permanent record.
| Time since nicotine use | Plasma nicotine | Serum cotinine | What it usually means |
|---|---|---|---|
| 0–2 hours | Often 5–30 ng/mL; higher with high-dose e-liquid | Rising, often 10–50 ng/mL | Recent use; source cannot be identified from cotinine alone |
| 2–8 hours | Falling, often 1–15 ng/mL | 50–300 ng/mL after smoking | Recent use; nicotine itself is fading |
| 8–24 hours | Often below 1–5 ng/mL; may be undetectable | 20–150 ng/mL | Cotinine is the better marker |
| 24–72 hours | Usually undetectable | 1–50 ng/mL | Typical positive window for occasional use |
| 3–5 days | Undetectable | Often below 10 ng/mL; may fall below cutoff | Negative at many clinical cutoffs |
| 5–7 days | Undetectable | Usually 1–5 ng/mL; heavy use may stay above 1 ng/mL | Low-level detection possible in heavy chronic users |
| 7 or more days | Undetectable | Usually below 1 ng/mL or undetectable | A positive result suggests recent heavy use, nicotine replacement, or a laboratory issue |
The 1-to-3-day window is typical for occasional use and a 10 ng/mL cutoff; a low 1 ng/mL cutoff can extend detection to about 5 to 7 days in heavy users, while a 15 ng/mL workplace cutoff can shorten it to about 2 to 3 days. Those thresholds are not contradictory because they ask different questions and use different cutoffs. Direct nicotine is a much shorter marker than cotinine. A sample drawn 24 hours after use may show no nicotine but a clear cotinine level.
Cutoffs: What Blood Levels Mean
Blood nicotine tests are usually quantitative. A laboratory reports a number and applies a cutoff for a defined question. For serum cotinine, common bands are below 1 ng/mL, 1 to 10 ng/mL, 10 to 15 ng/mL, and above 15 ng/mL. No single national cutoff applies to every purpose. Many clinical laboratories use 10 to 15 ng/mL to support a smoking-status classification. Research studies often use 3 ng/mL to flag smoke exposure. The CDC’s NHANES assay can detect cotinine near 0.015 ng/mL.
A value below 1 ng/mL is usually consistent with no recent exposure, but it can still be above the assay’s detection limit. A value from 1 to 10 ng/mL may reflect passive smoke, nicotine replacement, or a light or remote user. A value above 10 to 15 ng/mL strongly suggests active nicotine use, but it does not identify the product. Nicotine replacement can produce cotinine above 10 ng/mL, especially with patches or multiple products. A 10 ng/mL cutoff is about 667 times the 0.015 ng/mL detection limit, so a laboratory can detect exposure long before it calls a test positive for active smoking.
There is no blood nicotine cutoff for impairment, intoxication, or driving. Nicotine is not treated like alcohol in legal driving standards. In poisoning cases, nicotine levels correlate poorly with symptoms, and treatment is based on the clinical picture. Cotinine levels above 100 ng/mL are common in heavy smokers. Values above 300 ng/mL can occur with heavy use or recent high-dose nicotine replacement. The 3HC/COT ratio can estimate CYP2A6 activity, the liver enzyme that metabolizes nicotine. Slow metabolizers may have higher nicotine and lower cotinine, which can misclassify them at a fixed cutoff.
False Results and Edge Cases
False negatives are more common than false positives in blood nicotine testing, mostly because of timing. Direct nicotine can be undetectable within 8 to 24 hours, even after heavy use. A sample drawn 3 days after a cigarette may have cotinine below a 10 ng/mL cutoff but above a 0.015 ng/mL limit. That is not a laboratory error; it is a cutoff mismatch.
False positives from food are rare. Nicotine in tomatoes, potatoes, and eggplant is tiny, usually too low to push serum cotinine above 1 ng/mL. Secondhand smoke can raise cotinine, but usually into the low single digits. A nonsmoker in a smoky room rarely reaches 10 to 15 ng/mL unless exposure is extreme and repeated. In plain terms: passive exposure can explain a low positive, not a high one.
Source confusion is common. Nicotine gum, patches, and lozenges all raise nicotine and cotinine. E-cigarettes and nicotine pouches do the same. A standard cotinine test cannot tell tobacco from nicotine replacement. Anabasine and anatabine are minor tobacco alkaloids. When included, they can flag tobacco use because most nicotine replacement products lack them. This is more common in urine testing than in blood testing.
Biological variation matters. CYP2A6 slow metabolizers clear nicotine slowly and may have higher nicotine relative to cotinine. CYP2A6 inhibitors and liver disease can shift the ratio. Pregnancy increases nicotine metabolism by up to 50 to 100 percent in some studies, lowering cotinine for the same exposure. Kidney disease can alter clearance of cotinine and other metabolites. These edge cases do not make the test invalid; they make a single cutoff imperfect. Immunoassays can cross-react with related compounds, while LC-MS/MS resolves most of those issues. A positive immunoassay should be confirmed before legal action.
Blood vs Urine, Saliva, and Hair
Blood is quantitative and precise, but it is invasive and captures a short window. Urine is common for workplace and clinical testing because cotinine concentrates there. It is noninvasive, but dilution and kidney function matter. Saliva is easy to collect, but oral nicotine contamination can cause false positives. Hair gives months of history, but it cannot show recent use and can be contaminated by smoke or treatments.
| Matrix | Main markers | Typical detection window | Strengths | Limits |
|---|---|---|---|---|
| Blood serum or plasma | Nicotine and cotinine; some panels add 3HC | Nicotine 8–24 hours; cotinine 1–3 days, up to 5–7 days at a low cutoff in heavy use | Quantitative; useful for research and clinical correlation | Invasive; short window; cutoff dependent |
| Urine | Cotinine and 3HC; can include anabasine and anatabine | 2–4 days; heavy use 7–10 days | Noninvasive; concentrated; can test tobacco-specific alkaloids | Dilution and kidney function affect concentration |
| Saliva | Cotinine and nicotine | 1–3 days | Easy collection; useful for abstinence checks | Oral contamination from nicotine products |
| Hair | Nicotine and cotinine | About 1 cm per month; months of history | Long retrospective window | Cannot date recent use; external contamination; slower |
The comparison explains why a blood test and a urine test can disagree. Blood measures circulating exposure at a moment. Urine measures accumulated metabolite over hours to days. Per the 2019 SRNT update on biochemical verification, the choice of matrix and cutoff should match the question, not a generic drug-test label. A hair result can show long-term exposure but cannot prove use yesterday. A saliva result can be convenient but is easier to contaminate with nicotine products.
What to Actually Do Before and After a Test
Before a blood draw, disclose every nicotine product. List cigarettes and e-cigarettes. Include patches and gum. Also list lozenges and pouches. Give the last use time as precisely as possible. Ask the clinician or laboratory three questions: which analyte, which cutoff, and which method. If the result will affect employment, insurance, custody, or legal status, request a confirmatory LC-MS/MS test and chain-of-custody documentation.
For an abstinence check, cotinine is the better marker. A draw 3 to 7 days after the target quit date fits the typical 1-to-3-day window with margin. For heavy chronic users, a 7-day wait reduces false positives at a 1 ng/mL cutoff. For a source question, ask whether anabasine and anatabine are included. Those minor alkaloids can separate tobacco from most nicotine replacement products. For a legal or employment result, do not rely on a rapid immunoassay alone.
Treat these as red flags that require a clinician, laboratory director, or confirmatory test:
- A positive blood nicotine or cotinine result is not proof of impairment or acute poisoning.
- A result near the cutoff should be repeated with LC-MS/MS and a documented collection time.
- A high cotinine in a child or nonsmoker warrants exposure assessment, not immediate accusation.
- A test ordered for legal or employment reasons should use chain of custody and a confirmatory method.
- Severe vomiting, seizures, weakness, or arrhythmia after nicotine exposure needs emergency care, not a routine blood test.
Do not try to flush nicotine from blood by drinking water; blood concentration is not like urine dilution. Do not substitute a urine test for a blood test without understanding the different window. Do not treat a positive cotinine as proof of impairment or poisoning. The practical answer is to match the test to the question, document timing, and confirm borderline or consequential results.
Limitations of a Positive Blood Test
A positive blood nicotine or cotinine test proves exposure, not source, dose, or timing. It cannot tell whether the exposure came from a cigarette, e-cigarette, patch, gum, pouch, secondhand smoke, or a combination. It cannot prove impairment because there is no accepted nicotine impairment threshold. It cannot diagnose nicotine use disorder, which is a clinical diagnosis based on behavior and consequences.
Cutoffs are laboratory-specific and purpose-specific. A 10 ng/mL serum cotinine cutoff is useful for smoking-status research, but it is not a legal standard. A 0.015 ng/mL detection limit is useful for exposure research, but it is not a clinical diagnosis. The same number means different things in different contexts. Values in urine are often reported as ng/mL too, but urine concentrations are not interchangeable with blood concentrations.
Timing is the largest source of error. A single blood sample is a snapshot. Direct nicotine can disappear within 8 to 24 hours. Cotinine can fall below a clinical cutoff within 2 to 3 days in light users. Heavy users can remain positive for 5 to 7 days at a low cutoff. These numbers are ranges, not guarantees.
Individual metabolism, product type, and dose shift results. A slow CYP2A6 metabolizer may have a different nicotine-to-cotinine ratio. A fast metabolizer may clear cotinine sooner. Kidney and liver disease can alter clearance. Pregnancy can increase nicotine metabolism. None of these factors makes the test useless; they make interpretation a clinical and laboratory judgment.
Established science supports the half-lives and the exposure windows. Source discrimination and precise cutoff claims are more context-dependent. A positive result should be interpreted with the collection time, product history, cutoff, method, and confirmatory testing. Without those five pieces of context, a blood nicotine number is a laboratory value, not a complete answer.